Skip to content

Addiction: all studies

Page 104 of 855: studies 1,031 to 1,040 of 8,547, newest first. Back to the addiction overview

Research

Mindful attention reduces neural and self-reported cue-induced craving in smokers

Social Cognitive and Affective Neuroscience November 22, 2011 Cecilia Westbrook, J. David Creswell, Golnaz Tabibnia et al. 278 citations

An emerging body of research suggests that mindfulness-based interventions may be beneficial for smoking cessation and the treatment of other addictive disorders. One way that mindfulness may facilitate smoking cessation is through the reduction of craving to smoking cues. The present work considers whether mindful attention can reduce self-reported and neural markers of cue-induced craving in...

The anti-addictive drug ibogaine modulates voltage-gated ion channels and may trigger cardiac arrhythmias

BMC Pharmacology September 5, 2011 Michael Kovar, Xaver Koenig, Ágnes K. Mike et al. 5 citations

Background Ibogaine is an alkaloid derived from the African shrub Tabernanthe iboga. Psychoactive properties of ibogaine have been known for decades, but more recently the drug has received much attention because of its promising “anti-addictive” actions. Thus, ibogaine and its derivatives are being studied as potential treatment for opioid and stimulant abuse, as well as for alcoholism and...

DOI: 10.1186/1471-2210-11-s2-a1 (opens in new tab) Addiction Stimulant Pharmacology Qt interval +7

Ketamine use: a review

Addiction July 21, 2011 Celia J. A. Morgan, Helen Valerie Curran 645 citations

AIMS: Ketamine remains an important medicine in both specialist anaesthesia and aspects of pain management. At the same time, its use as a recreational drug has spread in many parts of the world during the past few years. There are now increasing concerns about the harmful physical and psychological consequences of repeated misuse of this drug. The aim of this review was to survey and integrate...

The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use.

Emerging health threats journal April 15, 2011 Sarbjeet S Kalsi, David M Wood, Paul I Dargan

Ketamine was originally synthesised for use as a dissociative anaesthetic, and it remains widely used legitimately for this indication. However, there is increasing evidence of non-medical recreational use of ketamine, particularly in individuals who frequent the night-time economy. The population-level and sub-population (clubbers) prevalence of recreational use of ketamine is not known but is...

DOI: 10.3402/ehtj.v4i0.7107 (opens in new tab) Full text (opens in new tab) Dependence Ketamine 2-2-chlorophenyl-2-methylamino-cyclohexanone Acute toxicity +4

Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers.

Substance Abuse and Rehabilitation April 1, 2011 Li-Tzy Wu, George E Woody, Chongming Yang et al. 40 citations

CONTEXT: Media and scientific reports have indicated an increase in recreational use of Salvia divinorum. Epidemiological data are lacking on the trends, prevalence, and correlates of S. divinorum use in large representative samples, as well as the extent of substance use and mental health problems among S. divinorum users. OBJECTIVE: To examine the national trend in prevalence of S. divinorum...

DOI: 10.2147/sar.s17192 (opens in new tab) Full text (opens in new tab) Substance use disorder Salvia divinorum use Substance-use disorder Substance use issues +2

Ibogaine therapy in the treatment of opiate dependency

Drugs and Alcohol Today December 2, 2010 Peter Brackenridge 6 citations

Ibogaine therapy offers a viable alternative to mainstream treatment for opiate addiction. The combination of the addiction‐arresting and fast‐acting properties of ibogaine, with the slow and thoughtful conversation of psychoanalytical psychotherapy is a novel approach to what still remains a difficult condition to overcome.Safer than methadone, ibogaine use is steadily increasing world‐wide,...

DOI: 10.5042/daat.2010.0724 (opens in new tab) Opiate Psychotherapist Modalities Addiction treatment +1

User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study

Journal of Substance Use July 30, 2010 R. L. Carhart-Harris, D. J. Nutt 108 citations

This study used a web-based questionnaire to investigate user perceptions of the benefits and harms of hallucinogenic drug use. Over 600 forms were submitted. Users were asked to comment on the acute and prolonged effects of different drugs and to provide more specific information on how particular drugs have harmed and/or helped them. Subjects reported relatively less harm associated with the...

A new classification of the psychoactive substances (stimulants, entactogens, hallucinogens)

Pharmacopsychiatry August 31, 2009 Torsten Passie

The classification of psychoactive substances (stimulants, entactogens, hallucinogens) in the frame of psychopharmacology was not worked on since the 1960s. Based on the authors empirical and theoretical research about the psychophysical correlates of waking altered states of consciousness, he lecture will present a recently developed new classification of psychoactive substances. Method: The...

Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats.

Psychopharmacology April 1, 2009 Lisa E Baker, John J Panos, Bryan A Killinger et al. 57 citations

Research interests regarding the psychopharmacology of salvinorin A have been motivated by the recreational use and widespread media focus on the hallucinogenic plant, Salvia divinorum. Additionally, kappa opioid (KOP) receptor ligands may have therapeutic potential in the treatment of some neuropsychiatric conditions, including drug dependence and mood disorders. Salvinorin A is a selective...

Neuroimaging in Human MDMA (Ecstasy) Users

Annals of the New York Academy of Sciences October 1, 2008 Ronald L Cowan, Deanne M. Roberts, James M. Joers 26 citations

MDMA (3,4 methylenedioxymethamphetamine) has been used by millions of people worldwide as a recreational drug. The terms “MDMA” and “Ecstasy” are often used synonymously, but it is important to note that the purity of Ecstasy sold as MDMA is not certain. MDMA use is of public health concern, not so much because MDMA produces a common or severe dependence syndrome, but rather because rodent and...